Largest CIDP Trial Offers Promising Results for Drug Combo Largest CIDP Trial Offers Promising Results for Drug Combo

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.MDedge News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | CIDP | Neurology | Neurosurgery